TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24906586

Group type: EXPERIMENTAL
Intervention: Randomized Healing (RH)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Self-Selected Healing (SH)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control (SC)
Number of subjects: 247
Study: 22261200

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 18699

Group type: COMPARATOR
Intervention: Non-PPI gastrointestinal drugs
Number of subjects: 18699

Group type: COMPARATOR
Intervention: No gastric therapy
Number of subjects: 18699
Study: 21061562

Group type: COMPARATOR
Intervention: Control (CON): Attended a single motivational lecture on weight loss.
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Weak Intervention (WI): Attended the motivational lecture, provided with textbooks, notebooks, and a pedometer.
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Strong Intervention (SI): Attended the motivational lecture, provided with the same tools as WI, and underwent a 6-month group-based support program (8 sessions).
Number of subjects: 188
Study: 17686110

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray 110 microg once daily (n = 605)
Number of subjects: 806

Group type: COMPARATOR
Intervention: Vehicle placebo nasal spray (n = 201)
Number of subjects: 806
Study: 15729552

Group type: EXPERIMENTAL
Intervention: Patient satisfaction questionnaire
Number of subjects: 2772

Group type: EXPERIMENTAL
Intervention: SF-36 quality of life assessment
Number of subjects: 2772

Group type: EXPERIMENTAL
Intervention: Patient-provider relationship, facility setting, and information on diagnosis and treatment options
Number of subjects: 2772
Study: 12196372

Group type: COMPARATOR
Intervention: CE (cisplatin 20 mg/m(2) and etoposide 100 mg/m(2) on days 1-3)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: CCE (carboplatin 200 mg/m(2) on day 1, cisplatin 30 mg/m(2) on days 2-3, etoposide 100 mg/m(2) on days 1-3)
Number of subjects: 65

Group type: COMPARATOR
Intervention: CE
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: CCE
Number of subjects: 65
Study: 9497183

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-Fat (HF) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobically trained athletes
Number of subjects: 0
Study: 7615269

Group type: EXPERIMENTAL
Intervention: 10 days' treatment with metronidazole and eight weeks' treatment with colloidal bismuth subcitrate (CBS) (84 patients)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: 10 days' treatment with metronidazole placebo and eight weeks with CBS (73 patients)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: ranitidine (82 patients)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: open triple therapy (CBS 120 mg four times daily, amoxicillin 500 mg four times daily, and metronidazole 400 mg three times daily) given to patients with ulcer relapse
Number of subjects: 239

Group type: COMPARATOR
Intervention: H pylori positive patients
Number of subjects: 239

Group type: COMPARATOR
Intervention: H pylori negative patients
Number of subjects: 239
Study: 2621541

Group type: EXPERIMENTAL
Intervention: WHOA! A Great Way To Say NO program
Number of subjects: 0
Study: 1153813

Group type: EXPERIMENTAL
Intervention: 15 (S) 15 methyl PGE2 (free acid)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 15 (S) 15 methyl PGE2 methyl ester
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 15 (S) 15 methyl PGF2alpha (free acid)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 15 (S) 15 methyl PGF2alpha methyl ester
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: mixture of 15 (S) 15 methyl PGE2 methyl ester and 15 (S) 15 methyl PGF2alpha methyl ester
Number of subjects: 125
Study: 30407030

Group type: EXPERIMENTAL
Intervention: Virtual walking (20 min)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Virtual wheeling (control)
Number of subjects: 59
Study: 28441381

Group type: EXPERIMENTAL
Intervention: Text-message reminder
Number of subjects: 8269

Group type: COMPARATOR
Intervention: No text-message reminder (Control)
Number of subjects: 8269
Study: 25380152

Group type: EXPERIMENTAL
Intervention: 10g cocoa (0, 80, 200, 500 and 800 mg cocoa flavonoids/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10g cocoa (80 mg cocoa flavonoids/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10g cocoa
Number of subjects: 20
Study: 23839178

Group type: EXPERIMENTAL
Intervention: 3mg Drospirenone/0.02 mg Ethinyl Estradiol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 21075695

Group type: EXPERIMENTAL
Intervention: Information brochure
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-intervention (control group)
Number of subjects: 50
Study: 19434504

Group type: EXPERIMENTAL
Intervention: 16-week exercise intervention
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Modeling analyses
Number of subjects: 101
Study: 18604044

Group type: EXPERIMENTAL
Intervention: Biphasic Positive Airway Pressure (BiPAP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Assisted Spontaneous Breathing (ASB)
Number of subjects: 30
Study: 14745876

Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (ABLC) 2.5 mg/kg intravenously 3 times weekly
Number of subjects: 201

Group type: COMPARATOR
Intervention: Liposomal amphotericin B (L-AmB) 3 mg/kg 3 times weekly
Number of subjects: 201
Study: 11673080

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamins C and E, plus selenium)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (beverage without selenium or antioxidants)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cisplatin‐based combination chemotherapy
Number of subjects: 27
Study: 8988721

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) at 500 mg/body weight/day for 7 days preoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no chemotherapy or radiotherapy)
Number of subjects: 20
Study: 8185365

Group type: EXPERIMENTAL
Intervention: Patient education programme and self management plan
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 3284754

Group type: EXPERIMENTAL
Intervention: Streptokinase plus streptodornase in saline
Number of subjects: 31

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 31
Study: 29043567

Group type: EXPERIMENTAL
Intervention: S-1 chemotherapy
Number of subjects: 380

Group type: COMPARATOR
Intervention: Taxane therapies
Number of subjects: 380
Study: 27895474

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (1.5 g/day for 10 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 50
Study: 24251442

Group type: EXPERIMENTAL
Intervention: Recombinant factor IX (rFIX) prophylaxis (BAX326)
Number of subjects: 0
Study: 22414841

Group type: EXPERIMENTAL
Intervention: Access cavity filled with core build-up composite
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Biproximal class III cavities filled as in group 1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Specimens restored as in group 2 with QFP placed
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Specimens decoronated and core buildup as in group 1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Specimens restored as in group 4 but with QFP as in group 3
Number of subjects: 40

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study: 20106684

Group type: EXPERIMENTAL
Intervention: St John's wort (Jarsin) administered t.i.d. for 15 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo administered t.i.d. for 15 days
Number of subjects: 12
Study: 18799995

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg x kg(‐1) body mass)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 21
Study: 15692981

Group type: EXPERIMENTAL
Intervention: Local steroid injection
Number of subjects: 163

Group type: COMPARATOR
Intervention: Surgical decompression
Number of subjects: 163
Study: 11850269

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (AmBisome) at 2 mg/kg body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amphotericin B deoxycholate at 0.6 mg/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (AmBisome)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (AmBisome) and Amphotericin B deoxycholate
Number of subjects: 0
Study: 10516938

Group type: EXPERIMENTAL
Intervention: Physiologic testosterone regimen
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Superphysiologic testosterone regimen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7627761

Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia with adrenaline (4 ml lidocaine 2% and 250 IU hyaluronidase with adrenaline)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia without adrenaline (4 ml lidocaine 2% and 250 IU hyaluronidase without adrenaline)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia with adrenaline
Number of subjects: 75
Study: 1957103

Group type: EXPERIMENTAL
Intervention: Slow-release oral salbutamol (SRS) 8 mg b.d.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Long-acting theophylline (T)
Number of subjects: 49
Study: 7138719

Group type: EXPERIMENTAL
Intervention: Extradural morphine 0.05 mg kg‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular morphine 0.1 mg kg‐1
Number of subjects: 20
Study: 31506097

Group type: EXPERIMENTAL
Intervention: Enhanced Triple P for Baby and Mellow Bumps
Number of subjects: 0
Study: 30073390

Group type: EXPERIMENTAL
Intervention: hu14.18-IL2 immunocytokine (IC) at 6 mg/m2/day i.v. on days 1, 2, and 3 of each 28-day course, 3 courses total.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: hu14.18-IL2 immunocytokine (IC)
Number of subjects: 20
Study: 26874298

Group type: EXPERIMENTAL
Intervention: Operating room temperature at 23°C (73°F)
Number of subjects: 791

Group type: COMPARATOR
Intervention: Operating room temperature at 20°C (67°F)
Number of subjects: 791
Study: 24671339

Group type: EXPERIMENTAL
Intervention: Mirtazapine (n=10)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Venlafaxine (n=10)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 35
Study: 22364352

Group type: EXPERIMENTAL
Intervention: Invariant manner of motion detection in infants aged 13 to 15 months (N = 30)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Reduced complexity of events (dampening the figure's path) for infants aged 10 to 12 months (N = 19)
Number of subjects: 49
Study: 19769548

Group type: EXPERIMENTAL
Intervention: Quetiapine (QTP) + Lithium (Li) or Divalproex (DVP)
Number of subjects: 1000
Study: 17714352

Group type: EXPERIMENTAL
Intervention: 5% amlexanox
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate magistral preparation
Number of subjects: 96
Study: 16516075

Group type: EXPERIMENTAL
Intervention: 300 mg clopidogrel pre-treatment for >=15 hours
Number of subjects: 1762

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1762
Study: 14624282

Group type: EXPERIMENTAL
Intervention: Modified, low-calorie diet with fat replacer (beta-glucans) and sweeteners (sucralose and fructose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: American Diabetic Association's nutrition recommendations diet
Number of subjects: 16
Study: 11004030

Group type: EXPERIMENTAL
Intervention: perflubron emulsion at 1.2 g PFC/kg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: perflubron emulsion at 1.8 g PFC/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: saline (3 mL/kg) control
Number of subjects: 48
Study: 8836591

Group type: EXPERIMENTAL
Intervention: 5-hydroxy-L-tryptophan (L-5-HTP) plus carbidopa
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo plus carbidopa
Number of subjects: 8
Study: 1535490

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Oxazepam 25 mg
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 6337266

Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed closure of wounds
Number of subjects: 0
Study: 31634295

Group type: EXPERIMENTAL
Intervention: Light physical activity (PA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Moderate physical activity (PA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Cadence bands of 40 to 59 steps per day and 60 to 79 steps per day
Number of subjects: 97

Group type: COMPARATOR
Intervention: Light PA
Number of subjects: 97
Study: 30198101

Group type: EXPERIMENTAL
Intervention: Digital intervention for action planning
Number of subjects: 88
Study: 27549782

Group type: EXPERIMENTAL
Intervention: Telerehabilitation (individualised exercise training at home on a treadmill, telemonitoring by a physiotherapist via videoconferencing, self-management via a customised website)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Treadmill (unsupervised exercise training at home)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study: 24756534

Group type: EXPERIMENTAL
Intervention: Press-fit fixation technique
Number of subjects: 158

Group type: COMPARATOR
Intervention: Interference screw fixation
Number of subjects: 158
Study: 23057417

Group type: EXPERIMENTAL
Intervention: Interferon treatment (IFN)
Number of subjects: 792

Group type: COMPARATOR
Intervention: No Interferon treatment
Number of subjects: 792

Group type: COMPARATOR
Intervention: General resident group
Number of subjects: 792
Study: 20138562

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 396

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 396
Study: 17413463

Group type: EXPERIMENTAL
Intervention: Methylprednisolone and bupivacaine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 15580451

Group type: EXPERIMENTAL
Intervention: 685-nm low level laser therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo laser treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (standardized wound care only)
Number of subjects: 44
Study: 12380631

Group type: EXPERIMENTAL
Intervention: Naproxen 400 mg
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Naproxen 200 mg
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Naproxen 400 mg and 200 mg
Number of subjects: 443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443

Group type: COMPARATOR
Intervention: Acetaminophen 1000 mg
Number of subjects: 443

Group type: COMPARATOR
Intervention: Ibuprofen 200 mg
Number of subjects: 443
Study: 10428106

Group type: EXPERIMENTAL
Intervention: Delavirdine + Zidovudine + Didanosine
Number of subjects: 544

Group type: COMPARATOR
Intervention: Two-drug combinations of Zidovudine and Didanosine
Number of subjects: 544
Study: 7484866

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2076225

Group type: EXPERIMENTAL
Intervention: Copalite varnish
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chelon‐Silver base
Number of subjects: 20

Group type: COMPARATOR
Intervention: IRM base
Number of subjects: 20

Group type: COMPARATOR
Intervention: No liner
Number of subjects: 20
Study: 6908095

Group type: EXPERIMENTAL
Intervention: Straight gravity drainage
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 6‐day progressive catheter clamping program
Number of subjects: 110
Study: 30280300

Group type: EXPERIMENTAL
Intervention: Single pass with a radiofrequency device (6.78 MHz)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Multiple passes with a radiofrequency device
Number of subjects: 25
Study: 26775711

Group type: EXPERIMENTAL
Intervention: Training of TBAs/CVs for 5 days in early feeding practices
Number of subjects: 1148

Group type: EXPERIMENTAL
Intervention: Training and supervision of TBAs/CVs
Number of subjects: 1148

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 1148
Study: 26268532

Group type: EXPERIMENTAL
Intervention: Intranasal scopolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25143025

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 22835011

Group type: EXPERIMENTAL
Intervention: High-level FK778 (H) 4 x 600 mg/day (4 days) followed by 120 mg/day
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Mid-level FK778 (M) 3 x 600 mg/day (3 days) followed by 110 mg/day
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Low-level FK778 (L) 2 x 600 mg/day (2 days) followed by 100 mg/day
Number of subjects: 364

Group type: COMPARATOR
Intervention: MMF 1 g/day (Control)
Number of subjects: 364
Study: 19238303

Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/die)
Number of subjects: 138
Study: 17964881

Group type: EXPERIMENTAL
Intervention: Aerobic exercise 3 times a week for 8 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Radiotherapy without exercise (Control)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Between-group comparison at post-radiotherapy assessment
Number of subjects: 21
Study: 15166299

Group type: EXPERIMENTAL
Intervention: Exercise weight loss (n = 17)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Diet weight loss (n = 15)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Exercise without weight loss (n = 12)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Weight-stable control group (n = 10)
Number of subjects: 54
Study: 11547642

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 gel
Number of subjects: 50

Group type: COMPARATOR
Intervention: Membrane sweeping
Number of subjects: 50
Study: 9676147

Group type: EXPERIMENTAL
Intervention: Karaoke therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple singing (Control)
Number of subjects: 0
Study: 7741836

Group type: EXPERIMENTAL
Intervention: First visual field tests
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Second visual field tests
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Time interval between tests
Number of subjects: 562
Study: 3377923

Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 39
Study: 31600271

Group type: EXPERIMENTAL
Intervention: Can do treatment (CDT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 158
Study: 28854538

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine delivered via target-controlled infusion
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine in the presence of ambient noise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dexmedetomidine in the absence of ambient noise
Number of subjects: 18
Study: 25599735

Group type: COMPARATOR
Intervention: Atorvastatin, 20 mg/d
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Atorvastatin with NER, 500 mg/d
Number of subjects: 105
Study: 23917392

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups (open and laparoscopic)
Number of subjects: 72
Study: 21185551

Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 73

Group type: COMPARATOR
Intervention: Suppression
Number of subjects: 73

Group type: COMPARATOR
Intervention: Acceptance
Number of subjects: 73
Study: 18638309

Group type: EXPERIMENTAL
Intervention: Baxter Xenium 170 high‐flux dialyzer (BX)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fresenius Optiflux 180 NR (FO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Gambro Polyflux 170 H (GP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: All filters
Number of subjects: 8
Study: 16513861

Group type: EXPERIMENTAL
Intervention: Competitive employment
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Other (noncompetitive) employment
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: No employment activity
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Access to rehabilitation services
Number of subjects: 1400
Study: 12756424

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine tooth patch (NTP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine tooth patch (NTP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 4.3 mg nicotine tooth patch (NTP)
Number of subjects: 10
Study: 14747959

Group type: EXPERIMENTAL
Intervention: Differentiated thyroid carcinoma patients
Number of subjects: 875
Study: 10319446

Group type: EXPERIMENTAL
Intervention: Individually administered mood induction procedure
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Group administered mood induction procedure
Number of subjects: 79

Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 79
Study: 7604809

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 2224356

Group type: EXPERIMENTAL
Intervention: Adrenaline infiltration prior to mastectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Adrenaline infiltration
Number of subjects: 20
Study: 81586

Group type: EXPERIMENTAL
Intervention: Supervised toothbrushing every second week during the school year, using a disclosing solution.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 200